[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Algernon Health Inc (AGN.CN)

Algernon Health Inc (AGN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 2,438
  • Shares Outstanding, K 5,418
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,717 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.72
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.66
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.70
  • Most Recent Earnings $-0.20 on 01/29/26
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0400 +12.50%
on 03/23/26
0.0550 -18.18%
on 04/16/26
+0.0050 (+12.50%)
since 03/17/26
3-Month
0.0350 +28.57%
on 03/16/26
0.0550 -18.18%
on 04/16/26
-0.0100 (-18.18%)
since 01/16/26
52-Week
0.0350 +28.57%
on 03/16/26
0.1000 -55.00%
on 06/16/25
-0.0400 (-47.06%)
since 04/17/25

Most Recent Stories

More News
Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation

VANCOUVER, British Columbia, April 15, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “ Company ” or “ Algernon ”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company,...

AGN.CN : 0.4500 (-10.00%)
AGNPF : 0.2998 (+2.25%)
Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation

VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “ Company ” or “ Algernon ”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company,...

AGN.CN : 0.4500 (-10.00%)
AGNPF : 0.2998 (+2.25%)
Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers

VANCOUVER, British Columbia, March 25, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to introduce NovaScan...

AGN.CN : 0.4500 (-10.00%)
AGNPF : 0.2998 (+2.25%)
Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building 

VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to announce that it...

AGN.CN : 0.4500 (-10.00%)
AGNPF : 0.2998 (+2.25%)
Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR  FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or...

AGN.CN : 0.4500 (-10.00%)
AGNPF : 0.2998 (+2.25%)
Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR  FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or...

AGN.CN : 0.4500 (-10.00%)
AGNPF : 0.2998 (+2.25%)
Algernon Closes Second Tranche of Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR  FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or...

AGN.CN : 0.4500 (-10.00%)
AGNPF : 0.2998 (+2.25%)
Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or...

AGN.CN : 0.4500 (-10.00%)
AGNPF : 0.2998 (+2.25%)
Algernon Closes First Tranche of its Recently Announced Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR  FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or...

AGN.CN : 0.4500 (-10.00%)
AGNPF : 0.2998 (+2.25%)
Algernon Health Announces Private Placement

VANCOUVER, British Columbia, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is...

AGN.CN : 0.4500 (-10.00%)
AGNPF : 0.2998 (+2.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Algernon Health Inc is a clinical-stage pharmaceutical development company focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), and stroke, including a program utilizing N,N-Dimethyltryptamine (DMT)....

See More

Key Turning Points

3rd Resistance Point 0.0450
2nd Resistance Point 0.0450
1st Resistance Point 0.0450
Last Price 0.4500
1st Support Level 0.0450
2nd Support Level 0.0450
3rd Support Level 0.0450

See More

Last Price 0.4500
52-Week High 0.1000
Fibonacci 61.8% 0.0752
Fibonacci 50% 0.0675
Fibonacci 38.2% 0.0598
52-Week Low 0.0350

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.